BCR and B-cell chronic lymphocytic leukemia: Dysregulation of these signaling networks entailed by impaired BCR-dependent signaling can lead to CLL cell demise by modulating the expression of molecules that govern apoptosis, a process that also scored among the most-enriched pathways in CLL cells upon treatment with EC-7072 (Figure 4D).